Implementation of recommendations for prevention of glucocorticosteroid-induced osteoporosis in hospitalized patients
Clin Rheumatol
.
2021 Oct;40(10):4361-4363.
doi: 10.1007/s10067-021-05820-6.
Epub 2021 Jun 22.
Authors
Tal Gazitt
1
,
Muna Elias
2
,
Joy Feld
2
,
Idit Lavi
3
,
Amir Haddad
2
,
Rema Bishara-Garzuzi
2
,
Muhanad Abu Elhija
4
,
Adi Kibari
5
,
Devy Zisman
2
6
Affiliations
1
Rheumatology Unit, Carmel Medical Center, Michal 7 St, 3436212, Haifa, Israel. tgazitt@gmail.com.
2
Rheumatology Unit, Carmel Medical Center, Michal 7 St, 3436212, Haifa, Israel.
3
Department of Community Medicine and Epidemiology, Carmel Medical Center, Haifa, Israel.
4
Rheumatology Unit and Internal Medicine A Ward, Carmel Medical Center, Haifa, Israel.
5
Rheumatology Unit and Internal Medicine B Ward, Carmel Medical Center, Haifa, Israel.
6
The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.
PMID:
34159492
DOI:
10.1007/s10067-021-05820-6
No abstract available
Publication types
Letter
MeSH terms
Glucocorticoids / adverse effects
Humans
Osteoporosis* / chemically induced
Osteoporosis* / drug therapy
Osteoporosis* / prevention & control
Substances
Glucocorticoids